Skip to main content

Clinical Trials › NCT03523858

Active, Not RecruitingPhase 3

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Sponsored by Hoffmann-La Roche

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
927
Target enrollment
13
U.S. states
May 2018
Start date
Nov 2026
Expected completion

Interventions / Treatments

Ocrelizumab

Conditions studied

Progressive Multiple Sclerosis (PMS)

Where this trial is running (18 sites)

California3 sites
Laguna Hills · Pasadena · San Francisco
Boston · Wellesley
Ohio2 sites
Cincinnati · Cleveland
Texas2 sites
Round Rock · San Antonio
North Haven
Florida1 site
Tampa
Illinois1 site
Chicago
Michigan1 site
Detroit
Missouri1 site
St Louis
New York1 site
Latham
Philadelphia
Tennessee1 site
Cordova
Seattle

MS centers in California

Compare treatment centers near a trial site by center type, providers and trials.

View California centers

More Phase 3 trials

Browse all Phase 3 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play